• Home
    • StockRanks™
    • Platform
        • Research & Discuss
        • Editorial & Community
        • Learn & Improve
        • Webinars & Masterclasses
        • Stockopedia Academy
    • Reviews
    • Pricing
    Get startedLog in
    SectorsHealthcareBiotechnology & Medical ResearchSavara
    Picture of Savara logo

    SVRA — Savara Share News

    $4.540.000.00%
    us flag iconLast trade - 00:00
    HealthcareAdventurousMid CapSucker Stock
    • Market Cap
      $932.79m
    • Enterprise Value
      $789.86m
    • Revenue
    • Quality
    • Value
    • Momentum
    • StockRank™
    • StockReport™
    • Accounts
      • Balance sheet
      • Income statement
      • Cashflow statement
      • Dividend summary
    • News
    • SVRA Dividends
    StockReport™
    Balance sheet
    Income statement
    Cashflow
    News
    SVRA Dividends
    • Savara Inc expected to post a loss of 10 cents a share - Earnings Preview

      10/05/2024 14:57
    • Brief: Savara Files For Mixed Shelf Of Up To $400 Mln

      09/05/2024 21:49
    • Brief: Savara Q1 Net Income USD -20.346 Million

      09/05/2024 21:05
    • Brief: Savara Inc Says Ricky Sun Not To Stand For Reelection To Board

      12/04/2024 23:02
    • Brief: Savara Reports Fourth Quarter Financial Results

      07/03/2024 21:56
    • Brief: Savara Q4 Net Income USD -16.099 Million

      07/03/2024 21:05
    • U.S. RESEARCH ROUNDUP-CommScope Holding Company, Dutch Bros, Hess Corp

      04/03/2024 07:01
    • Brief: Savara Inc- Apap Clearpath, Is Now Available To Physicians In U.S.

      21/12/2023 14:40
    • Brief: Savara Q3 Net Income USD -16.599 Million

      09/11/2023 21:05
    • Savara Inc reports results for the quarter ended in June - Earnings Summary

      10/08/2023 22:56
    • Brief: Savara Inc. Q2 basic EPS USD -0.07

      10/08/2023 21:45
    • Savara Inc expected to post a loss of 8 cents a share - Earnings Preview

      07/08/2023 12:48
    • Brief: Savara Added To Russell 3000 Index

      26/06/2023 22:09
    • Brief: Savara Completes Enrollment Of Phase 3 Impala-2 Trial Of Molgramostim Nebulizer Solution

      26/06/2023 13:38
    • U.S. RESEARCH ROUNDUP-Albemarle, Ellington Financial, Savara

      16/05/2023 07:43
    • Savara Inc reports results for the quarter ended in March - Earnings Summary

      15/05/2023 14:49
    • Brief: Savara Reports First Quarter Financial Results And Provides Business Update

      15/05/2023 13:11
    • Savara Inc expected to post a loss of 7 cents a share - Earnings Preview

      05/05/2023 12:15
    • U.S. RESEARCH ROUNDUP-Apple, Intel, Tesla

      03/04/2023 08:06
    • Savara Inc reports results for the quarter ended in December - Earnings Summary

      30/03/2023 21:59
    Previous12345Next

    Company

    • About us
    • Careers
    • Product Guide

    Our Coverage

    • Countries
    • Sectors
    • Ratios

    Top Stocks

    • UK Stocks
    • Australian Stocks
    • US Stocks

    Legals

    • Privacy Policy
    • Terms & Conditions
    • Disclaimer & FSG
    • Cookies
    Trustpilot
    Select a country/region:


    © Stockopedia 2026, Refinitiv, Share Data Services.

    *Past performance is no indicator of future performance, and testimonials are provided by third parties for informational purposes only and are not intended and should not be taken to be financial product advice. Performance returns are based on hypothetical scenarios and do not represent an actual investment.

    This site cannot substitute for professional investment advice or independent factual verification. To use Stockopedia, you must accept our Terms of use, Privacy and Disclaimer & FSG. All services are provided by Stockopedia Ltd, United Kingdom (company number 06367267). For Australian users: Stockopedia Ltd, ABN 39 757 874 670 is a Corporate Authorised Representative of Daylight Financial Group Pty Ltd ABN 77 633 984 773, AFSL 521404.